ARWR
Arrowhead Pharmaceuticals, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Arrowhead Pharmaceuticals, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report3 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−2.99%
vs ±8.5% implied · ×0.35
shaded = implied · ▲▼ = realized
Arrowhead Pharmaceuticals, Inc.
59.64
No thesis.
Expected move
Inputsspot 59.90exp Dec 18ATM strike 60ATM straddle 9.20IV 53%
Linked news
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $1.2B | 12.17% | −18.34% | |
| 2 | venBio Select AdvisorvenBio Select Advisor | $925.6M | 9.32% | +6.13% | |
| 3 | FMRFMR | $655.3M | 6.60% | +10.64% | |
| 4 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $517.7M | 5.21% | −11.12% | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $498.1M | 5.02% | +1.30% | |
| 6 | State StreetState Streetindex-like | $464.2M | 4.67% | −12.34% | |
| 7 | Norges BankNorges Bankindex-like | $317.6M | 3.20% | — | |
| 8 | InvescoInvesco | $316.6M | 3.19% | new | |
| 9 | Geode Capital ManagementGeodeindex-like | $298.8M | 3.01% | −17.49% | |
| 10 | Fred Alger ManagementFred Alger | $269.1M | 2.71% | −1.21% | |
| 11 | Baker Bros. AdvisorsBaker Bros. | $162.4M | 1.64% | 0.00% | |
| 12 | Susquehanna International GroupSusquehanna International | $153.9M | 1.55% | +2.84% | |
| 13 | SirenSiren | $139.8M | 1.41% | +6.19% | |
| 14 | Vestal Point CapitalVestal Point Capital | $128.4M | 1.29% | −30.77% | |
| 15 | Deerfield ManagementDeerfield | $113.2M | 1.14% | −11.71% | |
| 16 | First Trust AdvisorsFirst Trust | $110.3M | 1.11% | +807.10% | |
| 17 | Driehaus Capital ManagementDriehaus | $110.1M | 1.11% | +13.46% | |
| 18 | Jupiter TopcoJupiter Topco | $99.6M | 1.00% | — | |
| 19 | Northern TrustNorthern Trustindex-like | $97.2M | 0.98% | −27.96% | |
| 20 | Dimensional Fund AdvisorsDimensional | $96.3M | 0.97% | +94.17% | |
| 21 | Goldman Sachs GroupGoldman Sachs | $93.7M | 0.94% | −33.90% | |
| 22 | Bank of AmericaBank of America | $92.9M | 0.94% | +7.08% | |
| 23 | Hood River Capital ManagementHood River | $91.4M | 0.92% | +6.08% | |
| 24 | Holocene AdvisorsHolocene | $90.2M | 0.91% | new | |
| 25 | Morgan StanleyMorgan Stanley | $88.4M | 0.89% | +12.94% |
504 managers report $9.9B of Arrowhead Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 38 of them hold 80% of it; BlackRock is largest at 12.17%.